PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Theophile Bigirumurame
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Aritra Mukherjee
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Components of smartphone cognitive-behavioural therapy for subthreshold depression among 1093 university students: a factorial trial
Masatsugu Sakata
,
Rie Toyomoto
,
Kazufumi Yoshida
,
Yan Luo
,
Yukako Nakagami
,
Teruhisa Uwatoko
,
Tomonari Shimamoto
,
Aran Tajika
,
Hidemichi Suga
,
Hiroshi Ito
,
Michihisa Sumi
,
Takashi Muto
,
Masataka Ito
,
Hiroshi Ichikawa
,
Masaya Ikegawa
,
Nao Shiraishi
,
Takafumi Watanabe
,
Ethan Sahker
,
Yusuke Ogawa
,
Steven D Hollon
,
Linda M Collins
,
Edward R Watkins
,
James Wason
,
Hisashi Noma
,
Masaru Horikoshi
,
Taku Iwami
,
Toshi A Furukawa
May 2022
Cite
DOI
URL
Type
Journal article
Publication
Evidence Based Mental Health
Wason
Related
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty – protocol for a double-blind, randomised controlled proof-of-concept trial
The potential of innovative trial design for efficiently evaluating repurposed drugs
Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing
Cite
×